680
Participants
Start Date
April 16, 2018
Primary Completion Date
February 1, 2022
Study Completion Date
August 2, 2022
Incentives for negative EtG test
Economic incentives are given to the study participant contingent on point-of-care (POC) urine ethyl glucuronide (EtG) \<300 ng/mL with the amount of the incentive escalating with each subsequent negative EtG test.
Incentives for positive IsoScreen test
Economic incentives contingent on POC (IsoScreen) INH urine positive tests with the amount of the incentive escalating with each subsequent positive IsoScreen test.
Infectious Disease Research Collaboration (IDRC), Mbarara
Mbarara Regional Referral Hospital (MRRH): Immune Suppression Syndrome HIV, Mbarara
Infectious Diseases Research Collaboration, Uganda
OTHER
Mbarara University of Science and Technology
OTHER
University of California, San Francisco
OTHER